Global Medical Radioactive Microsphere Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Medical Radioactive Microsphere Injection market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 188 million by 2032 with a CAGR of 7.8% during the for... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global Medical Radioactive Microsphere Injection market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 188 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.Medical Radioactive Microsphere Injection is a radioactive therapeutic drug that uses vascular intervention to deliver microspheres (usually with a particle size of microns) loaded with radionuclides (such as yttrium [90Y], etc.) directly to the tumor blood supply artery or lesion site. This drug uses the difference in blood supply distribution between tumor tissue and normal tissue to selectively aggregate microspheres at the tumor site, and kills tumor cells at close range through the beta rays released by the decay of radionuclides in the microspheres, while reducing damage to surrounding normal tissues. It has the dual effects of internal radiotherapy and embolization, which can significantly improve the local control rate of tumors and prolong patient survival. It is suitable for the treatment of solid tumors such as primary liver cancer that cannot be surgically removed and liver metastasis of colorectal cancer. In 2025, the North America Medical Radioactive Microsphere Injection market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period. Major global manufacturers of Medical Radioactive Microsphere Injection include New Radiomedicine Technology, Grand Pharmaceutical Group Limited, YH Nu-Med, Boston Scientific, Sirtex Medical Limited, Terumo, ABK Biomedical, AtomVie, BWXT Medical, among others. In 2025, the top five players accounted for approximately % of global market revenue. In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %. The global Medical Radioactive Microsphere Injection market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032. Market Segmentation By Company: New Radiomedicine Technology Grand Pharmaceutical Group Limited YH Nu-Med Boston Scientific Sirtex Medical Limited Terumo ABK Biomedical AtomVie BWXT Medical Segment by Type Holmium 166 Microsphere Injection Yttrium 90 Microsphere Injection Others Segment by Application Cancer Treatment Diagnosis Others Macro-Region - North America - Europe - Asia-Pacific - South America - Middle East & Africa Micro-Local Market North America Europe China Japan India Chapter Outline Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term Chapter 2: Quantitative analysis of Medical Radioactive Microsphere Injection sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region Chapter 3: Competitive landscape of Medical Radioactive Microsphere Injection manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans) Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment) Chapter 7: Key manufacturer profiles –company overview, Medical Radioactive Microsphere Injection product descriptions and specifications, revenue, gross margins, and recent developments Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies Chapter 11: Key findings, main takeaways, and overall conclusions of the report. Why This Report? Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Medical Radioactive Microsphere Injection value chain, addressing: - Market entry risks/opportunities by region - Product mix optimization based on local practices - Competitor tactics in fragmented vs. consolidated markets Table of Contents1 Market Overview1.1 Medical Radioactive Microsphere Injection Product Scope 1.2 Medical Radioactive Microsphere Injection by Type 1.2.1 Global Medical Radioactive Microsphere Injection Sales by Type (2021, 2025 & 2032) 1.2.2 Holmium 166 Microsphere Injection 1.2.3 Yttrium 90 Microsphere Injection 1.2.4 Others 1.3 Medical Radioactive Microsphere Injection by Application 1.3.1 Global Medical Radioactive Microsphere Injection Sales Comparison by Application (2021, 2025 & 2032) 1.3.2 Cancer Treatment 1.3.3 Diagnosis 1.3.4 Others 1.4 Global Medical Radioactive Microsphere Injection Market Estimates and Forecasts (2021-2032) 1.4.1 Global Medical Radioactive Microsphere Injection Market Size (Value) and Growth Rate (2021-2032) 1.4.2 Global Medical Radioactive Microsphere Injection Market Size (Volume) and Growth Rate (2021-2032) 1.4.3 Global Medical Radioactive Microsphere Injection Price Trends (2021-2032) 1.5 Assumptions and Limitations 2 Market Size and Prospects by Region 2.1 Global Medical Radioactive Microsphere Injection Market Size by Region: 2021 VS 2025 VS 2032 2.2 Global Medical Radioactive Microsphere Injection Historical Market Scenario by Region (2021-2026) 2.2.1 Global Medical Radioactive Microsphere Injection Sales Market Share by Region (2021-2026) 2.2.2 Global Medical Radioactive Microsphere Injection Revenue Market Share by Region (2021-2026) 2.3 Global Medical Radioactive Microsphere Injection Market Estimates and Forecasts by Region (2027-2032) 2.3.1 Global Medical Radioactive Microsphere Injection Sales Estimates and Forecasts by Region (2027-2032) 2.3.2 Global Medical Radioactive Microsphere Injection Revenue Forecast by Region (2027-2032) 2.4 Major Regions and Emerging Market Analysis 2.4.1 North America Medical Radioactive Microsphere Injection Market Size and Prospects (2021-2032) 2.4.2 Europe Medical Radioactive Microsphere Injection Market Size and Prospects (2021-2032) 2.4.3 China Medical Radioactive Microsphere Injection Market Size and Prospects (2021-2032) 2.4.4 Japan Medical Radioactive Microsphere Injection Market Size and Prospects (2021-2032) 2.4.5 India Medical Radioactive Microsphere Injection Market Size and Prospects (2021-2032) 3 Global Market Size by Type 3.1 Global Medical Radioactive Microsphere Injection Historical Market Review by Type (2021-2026) 3.1.1 Global Medical Radioactive Microsphere Injection Sales by Type (2021-2026) 3.1.2 Global Medical Radioactive Microsphere Injection Revenue by Type (2021-2026) 3.1.3 Global Medical Radioactive Microsphere Injection Average Price by Type (2021-2026) 3.2 Global Medical Radioactive Microsphere Injection Market Estimates and Forecasts by Type (2027-2032) 3.2.1 Global Medical Radioactive Microsphere Injection Sales Forecast by Type (2027-2032) 3.2.2 Global Medical Radioactive Microsphere Injection Revenue Forecast by Type (2027-2032) 3.2.3 Global Medical Radioactive Microsphere Injection Price Forecast by Type (2027-2032) 3.3 Representative Players for Different Types of Medical Radioactive Microsphere Injection 4 Global Market Size by Application 4.1 Global Medical Radioactive Microsphere Injection Historical Market Review by Application (2021-2026) 4.1.1 Global Medical Radioactive Microsphere Injection Sales by Application (2021-2026) 4.1.2 Global Medical Radioactive Microsphere Injection Revenue by Application (2021-2026) 4.1.3 Global Medical Radioactive Microsphere Injection Average Price by Application (2021-2026) 4.2 Global Medical Radioactive Microsphere Injection Market Estimates and Forecasts by Application (2027-2032) 4.2.1 Global Medical Radioactive Microsphere Injection Sales Forecast by Application (2027-2032) 4.2.2 Global Medical Radioactive Microsphere Injection Revenue Forecast by Application (2027-2032) 4.2.3 Global Medical Radioactive Microsphere Injection Price Forecast by Application (2027-2032) 4.3 New Sources of Growth in Medical Radioactive Microsphere Injection Applications 5 Competition Landscape by Players 5.1 Global Medical Radioactive Microsphere Injection Sales by Player (2021-2026) 5.2 Global Top Medical Radioactive Microsphere Injection Players by Revenue (2021-2026) 5.3 Global Medical Radioactive Microsphere Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Medical Radioactive Microsphere Injection revenue as of 2025 5.4 Global Medical Radioactive Microsphere Injection Average Price by Company (2021-2026) 5.5 Global Key Manufacturers of Medical Radioactive Microsphere Injection, Manufacturing Sites & Headquarters 5.6 Global Key Manufacturers of Medical Radioactive Microsphere Injection, Product Type & Application 5.7 Global Key Manufacturers of Medical Radioactive Microsphere Injection, Date of Entry into This Industry 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans 6 Regional Analysis 6.1 North America Market: Players, Segments, Downstream and Major Customers 6.1.1 North America Medical Radioactive Microsphere Injection Sales by Company 6.1.1.1 North America Medical Radioactive Microsphere Injection Sales by Company (2021-2026) 6.1.1.2 North America Medical Radioactive Microsphere Injection Revenue by Company (2021-2026) 6.1.2 North America Medical Radioactive Microsphere Injection Sales Breakdown by Type (2021-2026) 6.1.3 North America Medical Radioactive Microsphere Injection Sales Breakdown by Application (2021-2026) 6.1.4 North America Medical Radioactive Microsphere Injection Major Customers 6.1.5 North America Market Trends and Opportunities 6.2 Europe Market: Players, Segments, Downstream and Major Customers 6.2.1 Europe Medical Radioactive Microsphere Injection Sales by Company 6.2.1.1 Europe Medical Radioactive Microsphere Injection Sales by Company (2021-2026) 6.2.1.2 Europe Medical Radioactive Microsphere Injection Revenue by Company (2021-2026) 6.2.2 Europe Medical Radioactive Microsphere Injection Sales Breakdown by Type (2021-2026) 6.2.3 Europe Medical Radioactive Microsphere Injection Sales Breakdown by Application (2021-2026) 6.2.4 Europe Medical Radioactive Microsphere Injection Major Customers 6.2.5 Europe Market Trends and Opportunities 6.3 China Market: Players, Segments, Downstream and Major Customers 6.3.1 China Medical Radioactive Microsphere Injection Sales by Company 6.3.1.1 China Medical Radioactive Microsphere Injection Sales by Company (2021-2026) 6.3.1.2 China Medical Radioactive Microsphere Injection Revenue by Company (2021-2026) 6.3.2 China Medical Radioactive Microsphere Injection Sales Breakdown by Type (2021-2026) 6.3.3 China Medical Radioactive Microsphere Injection Sales Breakdown by Application (2021-2026) 6.3.4 China Medical Radioactive Microsphere Injection Major Customers 6.3.5 China Market Trends and Opportunities 6.4 Japan Market: Players, Segments, Downstream and Major Customers 6.4.1 Japan Medical Radioactive Microsphere Injection Sales by Company 6.4.1.1 Japan Medical Radioactive Microsphere Injection Sales by Company (2021-2026) 6.4.1.2 Japan Medical Radioactive Microsphere Injection Revenue by Company (2021-2026) 6.4.2 Japan Medical Radioactive Microsphere Injection Sales Breakdown by Type (2021-2026) 6.4.3 Japan Medical Radioactive Microsphere Injection Sales Breakdown by Application (2021-2026) 6.4.4 Japan Medical Radioactive Microsphere Injection Major Customers 6.4.5 Japan Market Trends and Opportunities 6.5 India Market: Players, Segments, Downstream and Major Customers 6.5.1 India Medical Radioactive Microsphere Injection Sales by Company 6.5.1.1 India Medical Radioactive Microsphere Injection Sales by Company (2021-2026) 6.5.1.2 India Medical Radioactive Microsphere Injection Revenue by Company (2021-2026) 6.5.2 India Medical Radioactive Microsphere Injection Sales Breakdown by Type (2021-2026) 6.5.3 India Medical Radioactive Microsphere Injection Sales Breakdown by Application (2021-2026) 6.5.4 India Medical Radioactive Microsphere Injection Major Customers 6.5.5 India Market Trends and Opportunities 7 Company Profiles and Key Figures 7.1 New Radiomedicine Technology 7.1.1 New Radiomedicine Technology Company Information 7.1.2 New Radiomedicine Technology Business Overview 7.1.3 New Radiomedicine Technology Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.1.4 New Radiomedicine Technology Medical Radioactive Microsphere Injection Products Offered 7.1.5 New Radiomedicine Technology Recent Development 7.2 Grand Pharmaceutical Group Limited 7.2.1 Grand Pharmaceutical Group Limited Company Information 7.2.2 Grand Pharmaceutical Group Limited Business Overview 7.2.3 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.2.4 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Products Offered 7.2.5 Grand Pharmaceutical Group Limited Recent Development 7.3 YH Nu-Med 7.3.1 YH Nu-Med Company Information 7.3.2 YH Nu-Med Business Overview 7.3.3 YH Nu-Med Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.3.4 YH Nu-Med Medical Radioactive Microsphere Injection Products Offered 7.3.5 YH Nu-Med Recent Development 7.4 Boston Scientific 7.4.1 Boston Scientific Company Information 7.4.2 Boston Scientific Business Overview 7.4.3 Boston Scientific Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.4.4 Boston Scientific Medical Radioactive Microsphere Injection Products Offered 7.4.5 Boston Scientific Recent Development 7.5 Sirtex Medical Limited 7.5.1 Sirtex Medical Limited Company Information 7.5.2 Sirtex Medical Limited Business Overview 7.5.3 Sirtex Medical Limited Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.5.4 Sirtex Medical Limited Medical Radioactive Microsphere Injection Products Offered 7.5.5 Sirtex Medical Limited Recent Development 7.6 Terumo 7.6.1 Terumo Company Information 7.6.2 Terumo Business Overview 7.6.3 Terumo Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.6.4 Terumo Medical Radioactive Microsphere Injection Products Offered 7.6.5 Terumo Recent Development 7.7 ABK Biomedical 7.7.1 ABK Biomedical Company Information 7.7.2 ABK Biomedical Business Overview 7.7.3 ABK Biomedical Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.7.4 ABK Biomedical Medical Radioactive Microsphere Injection Products Offered 7.7.5 ABK Biomedical Recent Development 7.8 AtomVie 7.8.1 AtomVie Company Information 7.8.2 AtomVie Business Overview 7.8.3 AtomVie Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.8.4 AtomVie Medical Radioactive Microsphere Injection Products Offered 7.8.5 AtomVie Recent Development 7.9 BWXT Medical 7.9.1 BWXT Medical Company Information 7.9.2 BWXT Medical Business Overview 7.9.3 BWXT Medical Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026) 7.9.4 BWXT Medical Medical Radioactive Microsphere Injection Products Offered 7.9.5 BWXT Medical Recent Development 8 Medical Radioactive Microsphere Injection Manufacturing Cost Analysis 8.1 Medical Radioactive Microsphere Injection Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Suppliers of Raw Materials 8.2 Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Medical Radioactive Microsphere Injection 8.4 Medical Radioactive Microsphere Injection Industrial Chain Analysis 9 Marketing Channels, Distributors and Customers 9.1 Marketing Channels 9.2 Medical Radioactive Microsphere Injection Distributors List 9.3 Medical Radioactive Microsphere Injection Customers 10 Medical Radioactive Microsphere Injection Market Dynamics 10.1 Medical Radioactive Microsphere Injection Industry Trends 10.2 Medical Radioactive Microsphere Injection Market Drivers 10.3 Medical Radioactive Microsphere Injection Market Challenges 10.4 Medical Radioactive Microsphere Injection Market Restraints 11 Research Findings and Conclusion 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.1.1 Research Programs/Design 12.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 12.1.2 Data Source 12.1.2.1 Secondary Sources 12.1.2.2 Primary Sources 12.2 Author Details 12.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の 医薬・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD(injection)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|